Med Business World

Your source for healthcare business

transplantation

Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that Cell Stem Cell has published a paper titled “Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate.”…

Shaking Up Heart Transplant Eligibility: The Role of ‘Zombie’ Cells

A research team led by Dr. Gavin Richardson at Newcastle University is pioneering a study on ‘Zombie’ cells that could challenge existing practices in heart transplantation. The aim is to broaden the pool of available donor hearts, potentially bringing hope…

14-year-old Ethiopian boy undergoes complex kidney transplantation surgery at Aster CMI Hospital

A 14-year-old boy from Ethiopia with stunted growth and bony deformities was given a new lease of life by his father as a kidney donor at Aster CMI Hospital, Bangalore. The child was diagnosed with a condition called posterior urethral…